Developer docs
API playgroundTry for free, no card

Search company profiles

Sopartec

Full company profile

uuid000byid

Namestring
Sopartec
Websiteurl
sopartec.com
Company typeenum
Private
Founded yearint
1992
Descriptiontext

Sopartec is a Belgian technology transfer and investment company founded in 1992 and wholly owned by the Université catholique de Louvain (UCLouvain). The firm operates as the dedicated vehicle through which the university's research output is commercialized, evaluating, protecting, and licensing intellectual property generated within UCLouvain and supporting the creation of spin-off companies from the academic research base. Its primary constituency is the UCLouvain research community — faculty, doctoral researchers, and technology platforms — which supplies the underlying IP that Sopartec shepherds through patenting, licensing, and equity investment processes.

The company's core activity is spin-off creation and early-stage equity participation in ventures emerging from UCLouvain research. Sopartec works with academic inventors to assess commercial viability, secure patent protection, structure licensing agreements, and organize seed or Series A funding for nascent companies, frequently taking equity in lieu of or alongside cash fees. It also serves as a co-investment partner alongside external venture capital and corporate licensees who take downstream positions in UCLouvain-derived ventures. The technology base it works with spans the full breadth of UCLouvain's research output — life sciences, engineering, materials, ICT — and Sopartec's role is commercialization intermediation rather than primary technology development.

The business model is structurally different from a product or SaaS company. Revenue derives from a combination of equity upside on portfolio exits (IPO or trade sale of spin-offs), recurring licensing royalties on patented university IP, and service or management fees associated with the spin-off creation process. The firm operates with a small staff (1-10 employees) and is led by Philippe Durieux and Xavier Bastin as co-CEOs, with François Blondel as Director. Revenue cadence is inherently episodic — driven by exit and licensing events rather than contracted recurring streams — which is typical of mature university TTOs.

Short descriptiontext

Sopartec is the technology transfer and investment vehicle of the Université catholique de Louvain, founded in 1992 to commercialize university research through IP licensing, spin-off creation, and early-stage equity investment in UCLouvain-derived ventures.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersLouvain-la-neuve, Belgium
HQ citystring
Louvain-la-neuve
HQ countrystring
Belgium
HQ regionstring
Europe
Markets served

Serves global market

Keyword5 values
technology transfer services, university spin-off investment, research commercialization, intellectual property licensing, seed-stage venture investment
Industry1 code
PRIMARYEDAHABAH
Technology Transfer & Innovation-Driven Research Universities (High Commercialization)
NAICS code1 code
  • Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)541715
SIC code2 codes
  • Patent Owners & Lessors6794
  • Investment Advice6282
Product category
Technology Transfer and Research Commercialization Services
Social media profiles1 record
Cost components4 values
Personnel, Operations, Technology or R&D, Others
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

Sopartec is the technology transfer and investment arm of the Université catholique de Louvain. It supports the commercialization of university research by identifying, protecting, and licensing intellectual property, creating and funding spin-off companies, and managing equity investments in early-stage ventures emerging from UCLouvain's research base.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

No product information available. The source page displayed a verification/loading screen with no substantive company or product content.

Recent move2 records

Each record includes

Date, Type, Title, Description, Source

Peers10 records
TypeBroad incumbent
Description

EIF is the EU's specialist provider of risk finance to SMEs and a major LP in European university-affiliated seed funds. It is a broad incumbent in the same ecosystem Sopartec operates in, often co-investing alongside TTO vehicles.

TypeDirect peer
Description

Oxford University Innovation is the technology transfer and spin-out company of the University of Oxford. It operates the same TTO + equity model as Sopartec at significantly larger scale, making it a benchmark direct peer.

3Cambridge Enterprise
TypeDirect peer
Description

Cambridge Enterprise is the University of Cambridge's technology transfer office and seed investor. It is a leading European TTO with the same combination of licensing, spin-out creation, and fund management that Sopartec performs for UCLouvain.

TypeDirect peer
Description

ETH transfer is the technology transfer office of ETH Zurich, commercializing inventions and supporting spin-offs. It shares the same academic-TTO + equity mandate as Sopartec and is one of Europe's highest-performing university transfer offices.

TypeEmerging player
Description

VIB is a Belgian life sciences research institute with an active technology transfer and spin-off creation program. It is comparable to Sopartec as a Belgian academic research commercialization entity, though focused specifically on biotechnology.

TypeDirect peer
Description

Gemma Frisius Fund is KU Leuven's seed and early-stage investment vehicle, founded by the university to invest in academic spin-offs. It mirrors Sopartec's dual TTO + investor mandate and is the most directly comparable Belgian peer.

7KU Leuven Research & Development (LRD)
TypeDirect peer
Description

LRD is the technology transfer and spin-off creation office of KU Leuven, Belgium's other major research university. It is the closest direct peer to Sopartec in geography and operating model — TTO + equity participation in academic spin-offs.

TypeRegional player
Description

Novalis is a Belgian technology transfer and seed investment platform supporting academic life-science spin-offs. It overlaps with Sopartec in mandate and Belgian ecosystem presence.

TypeDirect peer
Description

Imperial Enterprise handles technology transfer, licensing, and spin-out creation for Imperial College London. Like Sopartec, it combines IP commercialization with seed-stage equity investment in academic spin-offs.

TypeRegional player
Description

Université Paris-Saclay operates a technology transfer office that commercializes research from one of France's largest university clusters. It is comparable in function to Sopartec but operates in a different national market.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat3 records

Each record includes

Type, Details

Key highlights5 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles3 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment4 records

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Sopartec

Technology Transfer and Research Commercialization Servicessopartec.com

Sopartec is the technology transfer and investment vehicle of the Université catholique de Louvain, founded in 1992 to commercialize university research through IP licensing, spin-off creation, and early-stage equity investment in UCLouvain-derived ventures.

What Sopartec does

Sopartec is a Belgian technology transfer and investment company founded in 1992 and wholly owned by the Université catholique de Louvain (UCLouvain). The firm operates as the dedicated vehicle through which the university's research output is commercialized, evaluating, protecting, and licensing intellectual property generated within UCLouvain and supporting the creation of spin-off companies from the academic research base. Its primary constituency is the UCLouvain research community — faculty, doctoral researchers, and technology platforms — which supplies the underlying IP that Sopartec shepherds through patenting, licensing, and equity investment processes.

The company's core activity is spin-off creation and early-stage equity participation in ventures emerging from UCLouvain research. Sopartec works with academic inventors to assess commercial viability, secure patent protection, structure licensing agreements, and organize seed or Series A funding for nascent companies, frequently taking equity in lieu of or alongside cash fees. It also serves as a co-investment partner alongside external venture capital and corporate licensees who take downstream positions in UCLouvain-derived ventures. The technology base it works with spans the full breadth of UCLouvain's research output — life sciences, engineering, materials, ICT — and Sopartec's role is commercialization intermediation rather than primary technology development.

The business model is structurally different from a product or SaaS company. Revenue derives from a combination of equity upside on portfolio exits (IPO or trade sale of spin-offs), recurring licensing royalties on patented university IP, and service or management fees associated with the spin-off creation process. The firm operates with a small staff (1-10 employees) and is led by Philippe Durieux and Xavier Bastin as co-CEOs, with François Blondel as Director. Revenue cadence is inherently episodic — driven by exit and licensing events rather than contracted recurring streams — which is typical of mature university TTOs.

Sopartec firmographics

Firmographics
Name
Sopartec
Website
https://sopartec.com
Company type
Private
Founded year
1992
Operating status
Operating
Headcount range
11–50 employees
Short description
Sopartec is the technology transfer and investment vehicle of the Université catholique de Louvain, founded in 1992 to commercialize university research through IP licensing, spin-off creation, and early-stage equity investment in UCLouvain-derived ventures.
Ownership category
akta.pro rank

Sopartec industry classification

Industry
Product category
Technology Transfer and Research Commercialization Services
NAICS
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) (541715)
SIC
Patent Owners & Lessors (6794), Investment Advice (6282)
akta.pro industry
PRIMARYEDAHABAH
Technology Transfer & Innovation-Driven Research Universities (High Commercialization)

Keywords

  • Technology transfer services
  • University spin-off investment
  • Research commercialization
  • Intellectual property licensing
  • Seed-stage venture investment

Where Sopartec is headquartered

Location

Headquarters

HQ city
Louvain-la-neuve
HQ country
Belgium
HQ region
Europe

Markets served

Sopartec business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Technology or R&D, Others

Sopartec product offering

Product offering

Core offering

Sopartec is the technology transfer and investment arm of the Université catholique de Louvain. It supports the commercialization of university research by identifying, protecting, and licensing intellectual property, creating and funding spin-off companies, and managing equity investments in early-stage ventures emerging from UCLouvain's research base.

Product overview

No product information available. The source page displayed a verification/loading screen with no substantive company or product content.

Differentiator

Problem solved

Functional benefit

Companies that use Sopartec

Customer profile

Ideal customer profiles1 record

Sopartec technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Sopartec partnerships and signals

Strategic signal

Recent moves2 records

Sopartec competitors and assessment

Company assessment

Broad incumbents

  • European Investment Fund (EIF): EIF is the EU's specialist provider of risk finance to SMEs and a major LP in European university-affiliated seed funds. It is a broad incumbent in the same ecosystem Sopartec operates in, often co-investing alongside TTO vehicles.

Direct peers

  • Oxford University Innovation: Oxford University Innovation is the technology transfer and spin-out company of the University of Oxford. It operates the same TTO + equity model as Sopartec at significantly larger scale, making it a benchmark direct peer.
  • Cambridge Enterprise: Cambridge Enterprise is the University of Cambridge's technology transfer office and seed investor. It is a leading European TTO with the same combination of licensing, spin-out creation, and fund management that Sopartec performs for UCLouvain.
  • ETH transfer (ETH Zurich): ETH transfer is the technology transfer office of ETH Zurich, commercializing inventions and supporting spin-offs. It shares the same academic-TTO + equity mandate as Sopartec and is one of Europe's highest-performing university transfer offices.
  • Gemma Frisius Fund: Gemma Frisius Fund is KU Leuven's seed and early-stage investment vehicle, founded by the university to invest in academic spin-offs. It mirrors Sopartec's dual TTO + investor mandate and is the most directly comparable Belgian peer.
  • KU Leuven Research & Development (LRD): LRD is the technology transfer and spin-off creation office of KU Leuven, Belgium's other major research university. It is the closest direct peer to Sopartec in geography and operating model — TTO + equity participation in academic spin-offs.
  • Imperial College Innovations (Imperial Enterprise): Imperial Enterprise handles technology transfer, licensing, and spin-out creation for Imperial College London. Like Sopartec, it combines IP commercialization with seed-stage equity investment in academic spin-offs.

Emerging players

  • VIB (Flemish Institute for Biotechnology): VIB is a Belgian life sciences research institute with an active technology transfer and spin-off creation program. It is comparable to Sopartec as a Belgian academic research commercialization entity, though focused specifically on biotechnology.

Regional players

  • Novalis Tech Transfer (Belgium): Novalis is a Belgian technology transfer and seed investment platform supporting academic life-science spin-offs. It overlaps with Sopartec in mandate and Belgian ecosystem presence.
  • Université Paris-Saclay Technology Transfer Office: Université Paris-Saclay operates a technology transfer office that commercializes research from one of France's largest university clusters. It is comparable in function to Sopartec but operates in a different national market.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat3 records

Key highlights5 records

Customer concentration

Sopartec social profiles

Digital presence

Sopartec financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Sopartec leadership team

Management profile

Number of profiles

Profiles3 records

Sopartec funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Sopartec M&A and investment

M&A and investment

M&A

Investments4 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Sopartec

What does Sopartec do?

Sopartec is the technology transfer and investment arm of the Université catholique de Louvain. It supports the commercialization of university research by identifying, protecting, and licensing intellectual property, creating and funding spin-off companies, and managing equity investments in early-stage ventures emerging from UCLouvain's research base.

When was Sopartec founded?

Sopartec was founded in 1992. It employs 11 to 50 people.

Where is Sopartec based?

Sopartec is headquartered in Louvain-la-neuve, Belgium, in the Europe region.

Who are Sopartec's main competitors?

European Investment Fund (EIF) is listed as a broad incumbent. Direct peers are Oxford University Innovation, Cambridge Enterprise, ETH transfer (ETH Zurich), Gemma Frisius Fund, KU Leuven Research & Development (LRD) and Imperial College Innovations (Imperial Enterprise). VIB (Flemish Institute for Biotechnology) is listed as an emerging player. Regional players are Novalis Tech Transfer (Belgium) and Université Paris-Saclay Technology Transfer Office.

Does Sopartec have an API?

No public API is recorded for Sopartec.

What industry is Sopartec in?

Sopartec's product category is Technology Transfer and Research Commercialization Services. Its primary akta.pro industry code is EDAHABAH, Technology Transfer & Innovation-Driven Research Universities (High Commercialization). Its NAICS code is 541715 and its SIC code is 6794.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals